维普期刊资源整合服务平台（V6.5）

337篇 您的检索式：作者名="Blanke CD"

选中清除导出查看参考文献查看引证文献引用追踪共17页首页上一页第1页下一页末页 /17 跳转

	题名	作者	年代	出处	被引量
1	Phase Ⅲ randomized,intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase:S0033显示文摘	Blanke CD Rankin C Demetri GD		0，，04：	3
2	Long-term results from a randomized phase Ⅱ trial of standard-versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT显示文摘	Blanke CD Demetri GD yon Mehren M		0，，04：	3
3	Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors显示文摘	Demetri GD von Mehren M Blanke CD		0，，：	2
4	Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors显示文摘	Demetri GD von Mehren M Blanke CD		0，，07：	2
5	Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors显示文摘	DEMETRI GD VON MEHREN M BLANKE CD	2002	N Engl J Med2002，347，：	1
6	Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies显示文摘	Heinrich MC Blanke CD Druker BJ	2002	J Clin Oncol2002，20，6：	1
7	Phase Ill randomized, in- tergroup trial assessing imatinibmesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromahumors express- ing the kit receptor tyrosine kinase: S0033 显示文摘	Blanke CD Rankin C Demetri GD	2008	J Clin Oncol2008，26，4：	1
8	Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors 显示文摘	Demetri GD von Mehren M Blanke CD	2002	N Engl J Med2002，347，：	1
9	Long-term re- sults from a randomized phase II trial of standard versus high- er-dose imatinib rnesylate for patients with unresectable or me- tastatic gastrointestinal stromal tumors expressing NIT显示文摘	Blanke CD Demetri GD yon Mehren M	2008	Clin Oncol2008，26，4：	1
10	NCCN task force report:management of patients with gastrointestinal stromal tumor(GIST)--update of the NCCN clinical practice guidelines显示文摘	Demetri GD Blanke CD	2007	J Natl Comp Cancer Network2007，52，：	1
11	Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors 显示文摘	Demetri GD von Mehren M Blanke CD	2002	N Engl J Med2002，347，7：	1
12	Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumor显示文摘	Demetri GD Von Mehren M Blanke CD	2002	N Engl Med2002，347，7：	1
13	Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors显示文摘	Demetri GD von Mehren M Blanke CD		0，，07：	1
14	Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors显示文摘	Demetri G van Mehren M Blanke CD	2002	N Engl J Med2002，347，7：	1
15	Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors 显示文摘	Demetri GD yon Mehren M Blanke CD	2002	N Engl J Med2002，347，7：	1
16	A phase Ⅱ trial of celecoxib,irinotecan,5-fluorouraciland leucovorin in patients with unresectable or metastatic colorectal cancer显示文摘	Blanke CD Benson A Dragovich T	2002	Proc Am Soc Clin Oncol2002，2，4：	1
17	Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors显示文摘	Demetri GD yon Mehren M Blanke CD	2002	N Engl J Med2002，347，7：	1
18	NCCN task force report: management of patients with gastrointestinal stromal tumor (GIST)-update of the NCCN clinical practice guidelines显示文摘	Demetri GD Benjamin RS Blanke CD	2007	J Natl Compr Canc Netw2007，5，2：	1
19	NCCN task force report : optimal management of patients with gastrointestinal stromal tumor (GIST) -expansion and update of NCCN clinical practice guidelines 显示文摘	Demetri GD Benjamin R Blanke CD	2004	J Natl Compr Canc Netw2004，21，：	1
20	NCCN Task Force report:management of patients with gastroin-testinal stromal tumor (GIST) -update of the NCCN clinical practice guidelines 显示文摘	Demetri GD Benjamin RS Blanke CD	2007	J Natl Comprehen Cancer Network2007，5，2：	1

返回顶部每页显示：

共17页首页上一页第1页下一页末页 /17 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示